Skip to Main Content

Paper Details

Initial eGFR Changes with Ertugliflozin and Associations with Clinical Parameters: Analyses from the VERTIS CV Trial.
Am J Nephrol
8
2022
Author NameAffiliation
David Z I CherneyUniversity of Toronto
Christopher P CannonBrigham and Women's Hospital, Harvard Medical School
  • 1 - 2

Datasets

Release 1.2